ARCTURUS THERAPEUTICS LTD's ticker is ARCT and the CUSIP is M1492T105. A total of 18 filers reported holding ARCTURUS THERAPEUTICS LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $128,000 | – | 16,171 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 33,184 | $183,000 | 0.16% |
| ARK Investment Management | 331,165 | $1,821,000 | 0.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 28,426 | $156,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 45,000 | $248,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 106,436 | $585,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 14,500 | $80,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,901 | $10,000 | 0.00% |
| CITIGROUP INC | 171 | $1,000 | 0.00% |
| MORGAN STANLEY | 38,862 | $214,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 9,746 | $54,000 | 0.00% |